The Rapid Response™ Legionella Urinary Antigen Test is an in-vitro rapid immunochromatographic assay for the qualitative detection of Legionella pneumophila antigen (L. pneumophila antigen) in urine specimens from patients with symptoms of pneumonia. It is intended to aid in the presumptive diagnosis of Legionella infection (Legionnaires’ disease) caused by L. pneumophila in conjunction with culture and other methods.
Outbreaks have occurred repeatedly in buildings such as hotels and hospitals. The Rapid Response™ Legionella Urinary Antigen Test allows for early diagnosis of Legionella pneumophila infection through detection of a specific soluble antigen present in the urine of patients with Legionnaires’ disease. Legionella pneumophila antigen has been detected in urine as early as three days after the onset of symptoms. The test is rapid, giving a result within 15 minutes, and utilizes a urine specimen which is convenient for collection, transport, and subsequent detection of early, as well as later, stages of disease.
- Test cassette
- Product insert
The Rapid Response™ Legionella Urinary Antigen Test is an in-vitro rapid immunochromatographic assay for the qualitative detection of Legionella pneumophila antigen (L. pneumophila antigen) in urine specimens from patients with symptoms of pneumonia. It is intended to aid in the presumptive diagnosis of Legionella infection (Legionnaires’ disease) caused by L. pneumophila in conjunction with culture and other methods.
Outbreaks have occurred repeatedly in buildings such as hotels and hospitals. The Rapid Response™ Legionella Urinary Antigen Test allows for early diagnosis of Legionella pneumophila infection through detection of a specific soluble antigen present in the urine of patients with Legionnaires’ disease. Legionella pneumophila antigen has been detected in urine as early as three days after the onset of symptoms. The test is rapid, giving a result within 15 minutes, and utilizes a urine specimen which is convenient for collection, transport, and subsequent detection of early, as well as later, stages of disease.
* The study was performed on 351 negative specimens (EIA confirmed) and 254 positive specimens (EIA confirmed) have been tested in the assays.
- Please note that certain products may only be available in specific regions; kindly consult with a sales representative for further information regarding product availability.
- The information provided on this website is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare professional regarding any medical concerns or conditions.
- Our products are intended for use as specified in the product documentation. It is important to carefully read and follow all instructions provided with the product.